Ocugen Provides Business Update with Second Quarter 2025 Financial Results
Provided By GlobeNewswire
Last update: Aug 1, 2025
Conference Call and Webcast Today at 8:30 a.m. ET
MALVERN, Pa., Aug. 01, 2025 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today reported second quarter 2025 financial results along with a business update.
Read more at globenewswire.com
